Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.
Yang X, Wang J, Zhou Y, Wang Y, Wang S, Zhang W.
Cancer Lett. 2012 Aug 28;321(2):137-43. Epub 2012 Jan 25.
Related citations
Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.
Abu-Yousif AO, Moor AC, Zheng X, Savellano MD, Yu W, Selbo PK, Hasan T.
Cancer Lett. 2012 Aug 28;321(2):120-7. Epub 2012 Jan 18.
Epigenetic biomarkers in epithelial ovarian cancer.
Gloss BS, Samimi G.
Cancer Lett. 2012 Jan 12. [Epub ahead of print]
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
Gloss BS, Patterson KI, Barton CA, Gonzalez M, Scurry JP, Hacker NF, Sutherland RL, O'Brien PM, Clark SJ.
Cancer Lett. 2012 May 1;318(1):76-85. Epub 2011 Dec 9.
Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.
Shah PP, Kakar SS.
Cancer Lett. 2011 Dec 1;311(1):66-76. Epub 2011 Jul 13.
Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, Chidiac J, Poletto B, Vannier JP, Varin R, Mirshahi M, Cazin L, Pujade-Lauraine E, Soria J, Soria C.
Cancer Lett. 2012 Apr 28;317(2):207-17. Epub 2011 Nov 25.
Live-attenuated measles virus vaccine confers cell contact loss and apoptosis of ovarian cancer cells via ROS-induced silencing of E-cadherin by methylation.
Zhou S, Li Y, Huang F, Zhang B, Yi T, Li Z, Luo H, He X, Zhong Q, Bian C, Lin X, Qi X, Liu P, Huang C, Zhao X, Wei Y.
Cancer Lett. 2012 May 1;318(1):14-25. Epub 2011 Nov 3.
CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells.
Lee KB, Byun HJ, Park SH, Park CY, Lee SH, Rho SB.
Cancer Lett. 2012 Feb 1;315(1):86-95. doi: 10.1016/j.canlet.2011.10.016. Epub 2011 Oct 21.
Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.
Chen X, Yan Q, Li S, Zhou L, Yang H, Yang Y, Liu X, Wan X.
Cancer Lett. 2012 Jan 1;314(1):41-53. Epub 2011 Sep 21.
Human ovarian cancer cell morphology, motility, and proliferation are differentially influenced by autocrine TGFβ superfamily signalling.
Thériault BL, Nachtigal MW.
Cancer Lett. 2011 Dec 26;313(1):108-21. Epub 2011 Sep 10.
Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Konishi I.
Cancer Lett. 2011 Nov 28;310(2):129-33. Epub 2011 Jul 8. Review.
Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition.
Sun H, Yu T, Li J.
Cancer Lett. 2011 Nov 1;310(1):118-28. Epub 2011 Jun 29.
Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
Tan D, Chen KE, Khoo T, Walker AM.
Cancer Lett. 2011 Nov 1;310(1):101-8. Epub 2011 Jun 25.
Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC, Hsu SC, Cheng YT, Shao WS, Wu K, Fang GS, Ou CC, Wang V.
Cancer Lett. 2011 Dec 1;311(1):11-9. Epub 2011 Jun 25.
Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
Solár P, Sytkowski AJ.
Cancer Lett. 2011 Oct 1;309(1):11-8. Epub 2011 Jun 14.
Purified autoantibodies against glucose-regulated protein 78 (GRP78) promote apoptosis and decrease invasiveness of ovarian cancer cells.
Cohen M, Petignat P.
Cancer Lett. 2011 Oct 1;309(1):104-9. Epub 2011 Jun 11.
Chemotherapy in epithelial ovarian cancer.
Pignata S, Cannella L, Leopardo D, Pisano C, Bruni GS, Facchini G.
Cancer Lett. 2011 Apr 28;303(2):73-83. Epub 2011 Feb 24. Review.
Molecular portraits of intratumoral heterogeneity in human ovarian cancer.
Choi YP, Shim HS, Gao MQ, Kang S, Cho NH.
Cancer Lett. 2011 Aug 1;307(1):62-71. doi: 10.1016/j.canlet.2011.03.018. Epub 2011 Apr 9.
Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α.
Su W, Huang L, Ao Q, Zhang Q, Tian X, Fang Y, Lu Y.
Cancer Lett. 2011 Jun 1;305(1):94-9. Epub 2011 Mar 21.
Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.
Schulte RR, Linkous AG, Hallahan DE, Yazlovitskaya EM.
Cancer Lett. 2011 May 28;304(2):137-43.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on